Franklin Berger

(Mr. Franklin Berger CFA)

Currently holds positions in ESSA Pharma Inc, Five Prime Therapeutics Inc, Atreca Inc, Proteostasis Therapeutics Inc and Kezar Life Sciences Inc

Positions
Position Company Period
Director ESSA Pharma Inc Jan. 1, 2016 -
Independent Director Five Prime Therapeutics Inc Sept. 1, 2010 -
Independent Director Atreca Inc Oct. 1, 2014 -
Independent Director Proteostasis Therapeutics Inc Feb. 1, 2016 -
Independent Director Kezar Life Sciences Inc Nov. 1, 2016 -
Independent Director Immune Design Corp March 1, 2014 - April 2, 2019
Independent Director ESSA Pharma Inc March 5, 2015 - Jan. 1, 2016
Independent Director Seagen Inc June 1, 2004 - May 16, 2014
Director Lineage Cell Therapeutics Inc May 13, 2013 - March 21, 2014
Director Asterias Biotherapeutics Inc June 1, 2013 - March 21, 2014
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-11-22 2023-11-21
B Purchase
23,259 +3.1%
5.73
133,274 USD 		23,259 +3.1% 5.73 133,274 USD
2023-11-16 2023-11-03
B Purchase
16,471 +2.2%
5.99
98,661 USD 		16,471 +2.2% 5.99 98,661 USD
2023-01-05 2022-12-21
S Sale
34,334 -4.8%
2.42
83,088 USD 		34,334 -4.8% 2.42 83,088 USD
2023-01-05 2022-12-21
S Sale
37,889 -5.0%
2.41
91,312 USD 		37,889 -5.0% 2.41 91,312 USD
2023-01-05 2022-12-20
S Sale
43,617 -5.5%
2.53
110,351 USD 		43,617 -5.5% 2.53 110,351 USD
2023-01-05 2022-12-16
S Sale
50,000 -5.9%
2.67
133,500 USD 		50,000 -5.9% 2.67 133,500 USD
2023-01-05 2022-12-15
S Sale
50,000 -5.6%
2.86
143,000 USD 		50,000 -5.6% 2.86 143,000 USD
2023-01-05 2022-12-15
S Sale
32,000 -3.4%
2.90
92,800 USD 		32,000 -3.4% 2.90 92,800 USD
2023-01-05 2022-12-14
S Sale
25,000 -2.6%
3.00
75,000 USD 		25,000 -2.6% 3.00 75,000 USD
2022-11-23 2022-11-22
B Purchase
77,000 +8.3%
8.27
636,790 USD 		77,000 +8.3% 8.27 636,790 USD
2022-11-23 2022-11-21
B Purchase
45,000 +5.1%
7.80
351,000 USD 		45,000 +5.1% 7.80 351,000 USD
2022-11-15 2022-11-14
S Sale
16,166 -2.0%
5.16
83,352 USD 		16,166 -2.0% 5.16 83,352 USD
2022-11-15 2022-11-11
S Sale
25,500 -3.1%
5.15
131,333 USD 		25,500 -3.1% 5.15 131,333 USD
2022-11-14 2022-11-08
B Purchase
42,881 +5.1%
5.83
249,996 USD 		42,881 +5.1% 5.83 249,996 USD
2022-03-22 2022-03-21
B Purchase
20,000 +2.3%
14.77
295,400 USD 		20,000 +2.3% 14.77 295,400 USD
2022-03-22 2022-03-18
B Purchase
45,000 +5.4%
17.00
765,000 USD 		45,000 +5.4% 17.00 765,000 USD
2022-03-22 2022-03-18
B Purchase
15,000 +1.9%
15.96
239,400 USD 		15,000 +1.9% 15.96 239,400 USD
2021-04-27 2021-04-23
B Purchase
5,000 +4.2%
15.78
78,900 USD 		5,000 +4.2% 15.78 78,900 USD
2021-04-27 2021-04-23
B Purchase
120,000 +inf%
17.00
2,040,000 USD 		120,000 +inf% 17.00 2,040,000 USD
2021-03-04 2021-02-22
B Purchase
57,000 +6.3%
27.00
1,539,000 USD 		57,000 +6.3% 27.00 1,539,000 USD
2020-11-03 2020-11-03
B Purchase
41,666 +5.4%
24.00
999,984 USD 		41,666 +5.4% 24.00 999,984 USD
2020-06-11 2020-06-11
B Purchase
100,000 +14.6%
5.50
550,000 USD 		100,000 +14.6% 5.50 550,000 USD
2020-02-05 2020-02-04
B Purchase
120,846 +21.5%
2.60
314,200 USD 		120,846 +21.5% 2.60 314,200 USD
2013-08-22 2013-08-20
B Purchase
500 +inf%
3.71
1,855 USD 		500 +inf% 3.71 1,855 USD